Kenneth Cardona
Emory University
SurgeryPathologyNeuroendocrine tumorsGeneral surgeryMedicine
What is this?
Publications 153
#1Rachel M. LeeH-Index: 1
#2Yuan LiuH-Index: 20
Last. Shishir K. MaithelH-Index: 38
view all 8 authors...
Abstract Background Inequities in cancer survival are well documented. Whether disparities in overall survival (OS) result from inherent racial differences in underlying disease biology or socioeconomic factors (SEF) is not known. Our aim was to define the association of race/ethnicity and SEF with OS in pts with cholangiocarcinoma (CCA). Methods Patients with CCA of all sites and stages in the National Cancer Data Base (2004-13) were included. Racial/ethnic groups were defined as non-Hispanic W...
#1Alexander Dabrowiecki (Emory University)
#2Tina Sankhla (Emory University)
Last. Nima Kokabi (Emory University)H-Index: 11
view all 9 authors...
PURPOSE: To investigate timing of Yttrium-90 radioembolization (Y90) during treatment course, genomics, and other clinical factors as predictors of overall survival (OS) in colorectal liver metastasis (CRLM) that have progressed on at least one line of chemotherapy. MATERIALS AND METHODS: This was a retrospective study from 2013 to 2018 of patients with CRLM and genomic analysis prior to Y90 at a multihospital tertiary referral center. OS from liver metastasis diagnosis and predictors of OS were...
#1Walid L. Shaib (Emory University)H-Index: 12
#2Katerina Mary Zakka (Emory University)
Last. Bassel F. El-Rayes (Emory University)H-Index: 29
view all 13 authors...
Abstract Objective Surgical resection remains the only potentially curative therapy for pancreatic ductal adenocarcinoma (PDAC). There is paucity of literature about morbidity and mortality in older patients with PDAC undergoing pancreaticoduodenectomy. This retrospective analysis evaluates the in-hospital 30-day mortality of this population utilizing the Nationwide Inpatient Sample (NIS) database. Subjects and Methods All US patients hospitalized for pancreaticoduodenectomy (Whipple procedure) ...
#1Takashi Muraki (Emory University)H-Index: 18
#2Michelle D. Reid (Emory University)H-Index: 20
Last. Pardeep Kumar Mittal (Emory University)H-Index: 14
view all 21 authors...
BACKGROUND: The cause of most pancreatic and periampullary cancers (PAC) is unknown. Recently, anatomic variations such as pancreatobiliary maljunction have been recognized as risk factors, similar to Barrett-related gastro-esophageal cancers. METHODS: Pre-operative MRI from 860 pancreatic/biliary resections, including 322 PACs, were evaluated for low-union (cystic duct joining the common hepatic duct inside of the pancreas or within 5 mm of the pancreatic border) RESULTS: Low-union, seen <10% o...
#1Rita D. Shelby (OSU: Ohio State University)H-Index: 1
#2Lorena P. Suarez-Kelly (OSU: Ohio State University)H-Index: 4
Last. Harveshp Mogal (Wake Forest University)H-Index: 12
view all 21 authors...
BACKGROUND AND OBJECTIVES: Radiation improves limb salvage in extremity sarcomas. Timing of radiation therapy remains under investigation. We sought to evaluate the effects of neoadjuvant radiation (NAR) on surgery and survival of patients with extremity sarcomas. MATERIALS AND METHODS: A multi-institutional database was used to identify patients with extremity sarcomas undergoing surgical resection from 2000-2016. Patients were categorized by treatment strategy: surgery alone, adjuvant radiatio...
#1Sam Z. Thalji (MCW: Medical College of Wisconsin)
#2Susan Tsai (MCW: Medical College of Wisconsin)H-Index: 23
Last. Kevin K. Roggin (U of C: University of Chicago)H-Index: 29
view all 15 authors...
BACKGROUND AND OBJECTIVES: Outcomes of palliative-intent surgery in retroperitoneal sarcomas (RPS) are not well understood. This study aims to define indications for and outcomes after palliative-intent RPS resection. METHODS: Using a retrospective 8-institution database, patients undergoing resection of primary/recurrent RPS with palliative intent were identified. Logistic regression and Cox-proportional hazards models were constructed to analyze factors associated with postoperative complicati...
#1Patrick B. Schwartz (UW: University of Wisconsin-Madison)
#2George A. Poultsides (Stanford University)H-Index: 31
Last. Emily R. Winslow (UW: University of Wisconsin-Madison)H-Index: 17
view all 9 authors...
Abstract Background Elevations in inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR) or platelet-to-lymphocyte ratio (PLR), are reportedly associated with decreased overall survival (OS) or recurrence-free survival (RFS) in patients with numerous cancers. A large multicenter sarcoma data set was used to determine if elevated NLR or PLR was associated with worse survival and can guide treatment selection. Materials and methods A total of 409 patients with a primary retroperit...
Last. David A. KoobyH-Index: 46
view all 10 authors...
BACKGROUND: Existing research suggests patients with blood group O are less likely to develop pancreatic ductal adenocarcinoma (PDAC) compared to those with non-O blood groups, and that survival from PDAC may be affected by ABO blood type. This study assessed survival outcomes in PDAC patients who underwent pancreatoduodenectomy (PD) in one health system. METHODS: From 2010 to 2017, demographic, operative, chemotherapy and survival data for patients undergoing PD at Emory Healthcare were reviewe...